Leavell Investment Management Inc. Purchases 5,297 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Leavell Investment Management Inc. increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 19.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,653 shares of the company’s stock after purchasing an additional 5,297 shares during the period. Leavell Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $2,553,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. Cherry Creek Investment Advisors Inc. lifted its stake in GE HealthCare Technologies by 0.3% during the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company’s stock worth $2,920,000 after purchasing an additional 114 shares during the period. Independence Bank of Kentucky raised its holdings in shares of GE HealthCare Technologies by 6.0% in the 4th quarter. Independence Bank of Kentucky now owns 2,018 shares of the company’s stock worth $158,000 after buying an additional 114 shares in the last quarter. Tandem Capital Management Corp ADV lifted its position in shares of GE HealthCare Technologies by 0.4% during the 4th quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company’s stock worth $2,205,000 after buying an additional 118 shares during the period. Custom Index Systems LLC boosted its stake in GE HealthCare Technologies by 4.4% in the 4th quarter. Custom Index Systems LLC now owns 2,843 shares of the company’s stock valued at $222,000 after buying an additional 120 shares in the last quarter. Finally, Greenleaf Trust boosted its stake in GE HealthCare Technologies by 1.7% in the 3rd quarter. Greenleaf Trust now owns 7,619 shares of the company’s stock valued at $715,000 after buying an additional 124 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $96.77.

GE HealthCare Technologies Trading Down 1.3 %

Shares of NASDAQ GEHC opened at $85.90 on Thursday. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.55. The company has a 50-day moving average of $83.58 and a two-hundred day moving average of $85.39. The company has a market cap of $39.25 billion, a PE ratio of 23.60, a P/E/G ratio of 2.93 and a beta of 1.15. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is 3.85%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.